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ABSTRACT A systematic approach for improving protein crystals by growing them in the metastable zone using the vapor
diffusion technique is described. This is a simple technique for optimization of crystallization conditions. Screening around
known conditions is performed to establish a working phase diagram for the crystallization of the protein. Dilutions of the
crystallization drops across the supersolubility curve into the metastable zone are then carried out as follows: the coverslips
holding the hanging drops are transferred, after being incubated for some time at conditions normally giving many small
crystals, over reservoirs at concentrations which normally yield clear drops. Fewer, much larger crystals are obtained when the
incubation times are optimized, compared with conventional crystallization at similar conditions. This systematic approach has
led to the structure determination of the light-harvesting protein C-phycocyanin to the highest-ever resolution of 1.45 A˚.
INTRODUCTION
The detailed understanding of three-dimensional protein
structure is important in the design of new drugs and for
engineering proteins with improved properties for industrial
applications. X-ray diffraction is the most powerful method
to determine the structure of such large molecules but can be
applied only when suitable crystals are obtained.
Crystallization has always been a difficult step, often
referred to as the ‘‘bottleneck’’ to structure determination.
The urgent need to develop efficient crystallization methods
is further highlighted in this era of structural genomics,
where production of diffraction-quality crystals is crucial to
the success of the next step of the genome project.
Biocrystallization, like any other crystallization, is a pro-
cess involving the steps of nucleation and growth, where
molecules have to be brought into a supersaturated,
dynamically unstable state. However, the supersaturation
level required for the nucleation step is higher than that
required for the growth of existing postcritical nuclei.
Nucleation is a prerequisite and the first step to crystal
growth, yet excess nucleation causes the production of a large
number of small crystals instead of a smaller number of
useful ones (Feher and Kam, 1985; Chayen, 1997a). The
optimum conditions for crystal growth are thought to be in
a metastable zone of conditions, which allows growth
without the production of further nuclei (Ataka, 1993;
McPherson, 1999; Ducruix and Giege´, 1992; Stura and
Wilson, 1992).
The aim is to control crystal growth by separating the phases
of nucleation and growth, i.e., to start the process at
conditions that induce nucleation and then transfer the
nuclei to metastable conditions. The most widely used
method for separation is seeding, that is, transferring whole
crystals, crushed crystals or precipitate from the nucleating
drops into metastable drops (Stura, 1999). Other methods
involve changing of the temperature (Rosenberger et al.,
1993; Haire Lloyd, 1996) or diluting microbatch drops after
incubating them for a given time at spontaneous nucleation
conditions (Saridakis et al., 1994). In both cases, the
optimum time for intervention was long before the
appearance of the first visible crystals. A method for slowing
down the rate of evaporation of a droplet was designed by
applying a double cell for changing reservoir concentrations
during crystal growth. This was used successfully in the
crystallization of the Brucella abortus-specific Fab (Przy-
bylska, 1989). A simpler way of achieving the same is by
placing an oil barrier over the reservoirs of vapor diffusion
trials (Chayen, 1997b). This technique has enabled the
successful crystallization of a titin kinase domain after years
of failure using standard crystallization methods (Mayans et
al., 1998).
The area of conditions called the ‘‘metastable zone’’ lies
between the solubility and supersolubility curves on
a crystallization phase diagram of a macromolecule. The
supersolubility curve is defined as the line separating
conditions where spontaneous nucleation (or phase separa-
tion, precipitation) occurs from those where the crystalliza-
tion solution remains supersaturated without the formation of
a solid phase for an indefinite length of time if it is left
undisturbed (Ducruix and Giege´, 1992).
The supersolubility curve is less well defined than the
solubility curve but experimentally, it is found to a reasonable
approximation much more easily. To construct it, one must
set up many crystallization trials, varying at least two
conditions (one of which is typically the protein concentra-
tion) and plot their outcomes, after 3–4 weeks, on a two- or
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many-dimensional parameter grid. These experiments may
be called ‘‘static,’’ by contrast to the ‘‘dynamic’’ experi-
ments involving seeding or some process of nucleation
inducement. The static experiments will show where on the
grid (i.e., for which conditions) the crystallization solution
remains clear and where it spontaneously nucleates or
precipitates. The line dividing the two regions is the
supersolubility curve. The automated microbatch technique
(Chayen et al., 1990; 1992) is perfectly suited for such
experiments.
When the supersolubility curve has been determined, the
metastable zone can be accessed for the growth of nuclei into
crystals by dilution experiments such as the ones described
here, or by seeding, etc. Knowledge of the supersolubility
curve means that informed decisions can be made as to
which conditions are metastable.
We have shown improvement of human serum albumin
crystals in hanging drops by diluting the reagents after
a certain incubation time (Saridakis and Chayen, 2000).
Conditions were at the time selected merely by trial and
error. The present communication presents the use of
supersolubility curves as a systematic approach for growing
protein crystals in the metastable zone utilizing the hanging
drop technique. The method does not involve handling of
the crystals.
MATERIALS AND METHODS
Pure, crystallized trypsin from porcine pancreas was purchased from Sigma
(Steinheim, Germany, Cat. No. T-0134). It was dissolved to various stock
concentrations with deionized water. Solutions of C-phycocyanin were
prepared as described by Nield (1997) to a stock concentration of 70 mg/ml.
Trizma base, MES, and ammonium sulfate were purchased from Sigma.
Determination of the supersolubility curve
Using the automated microbatch method (IMPAX), which consists of
a computer-controlled robot that rapidly dispenses numerous small-volume
crystallization trials, two-dimensional phase diagrams were obtained for two
proteins, trypsin and C-phycocyanin, by varying the concentrations of
protein and precipitating agent until the supersolubility curve could be
determined. All trials were performed at 208C. Trypsin was crystallized from
ammonium sulfate and 100 mM Tris, pH 8.4 (Christopher et al., 1998).
C-phycocyanin was crystallized from ammonium sulfate and 40 mM MES,
pH 6.1.
Additional trials were performed to adjust the phase diagrams to vapor
diffusion conditions (see Results and Discussion). These were performed in
hanging drops as described below.
Separation of the nucleation and growth phases
The separation between the nucleation and growth stages was performed as
follows. First, the hanging drops were incubated for some time at conditions
normally giving many small crystals. The coverslips were then transferred
over reservoirs containing precipitant concentrations that normally yield
clear drops.
The wells of Linbro and VDX crystallization plates contained 1 ml of the
reservoir solutions. The drops were dispensed on silanized glass coverslips
that were inverted above the wells at the initial conditions (see Results and
Discussion) and sealed with Apiezon C oil (M&I Materials, Manchester,
UK). The initial drops consisted of 1 ml of protein stock mixed with 1 ml of
well solution. The dilution experiments consisted in transferring each
coverslip, after incubation, over a well containing a lower concentration of
precipitating agent (ammonium sulfate). The rim of the new well had already
been covered with Apiezon C oil, to form a new seal. Each transfer of
a coverslip between the wells was carried out in 1–2 s. All the transfer trials
were performed in duplicate for each incubation time in the case of
C-phycocyanin, and in triplicate for trypsin. Controls set initially at the
nucleation (high supersaturation) and at the metastable (low supersaturation)
conditions and left undisturbed were also set up for every experiment, in
triplicate. An experiment was considered successful if the low supersatu-
ration controls (considered then to belong to the metastable zone) stayed
clear for at least 3 weeks, inasmuch as good crystals appeared in the transfer
trials before that time. Successful experiments, therefore, were those where
single crystals appeared in the drop because it was diluted to true metastable
conditions, rather than just to the low side of the spontaneous nucleation
zone, where crystals would appear in any case.
At least a dozen repeat experiments were conducted over several months
for each protein to ensure reproducibility of the reported results. The crystals
were x-rayed at room temperature, using an Enraf-Nonius GX21 rotating
anode CuKa source with MAR image plate detector.
RESULTS AND DISCUSSION
Two phase diagrams are presented in Fig. 1: trypsin (Fig. 1
a) and C-phycocyanin (Fig. 1 b). These are, of course, not
complete, true phase diagrams, because the solubility curve
has not been determined; we therefore call them ‘‘working
phase diagrams,’’ because they are sufficient for our purpose
of separating the phases of nucleation and growth.
The dilution experiments described here involve the
method of vapor diffusion in hanging drops. It has been
shown (Chayen, 1998) that some adaptation of the batch
conditions to the vapor diffusion method is necessary;
therefore, some more experiments were done, with vapor
diffusion, to establish a correspondence of the working phase
diagrams with the vapor diffusion situation. The agreement
was perfect in the case of C-phycocyanin, and only minor
adjustments had to be made to the trypsin diagram to fit the
vapor diffusion results (the diagram presented here is the one
adjusted to vapor diffusion).
The arrows connect initial and final conditions of
successful dilution experiments. It can be seen that the
successful starting (spontaneous nucleation) conditions are
well beyond the supersolubility curve. The endpoints of the
arrows show the conditions that sustained crystal growth
when drops which had been incubated at nucleation
conditions were transferred to them. Drops which were set
at these conditions without previous incubation remained
clear for at least 3 weeks, showing that they belong to the
metastable zone.
For trypsin, incubation times of 0, 2.5, 4.5, 6, 7, and 9 h
were tried for the various conditions in the nucleation zone
shown in Fig. 1 a. The chosen initial conditions mostly
yielded crystals overnight when left undisturbed, and
therefore our chosen incubation times span a range of
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possible nucleation induction times within that interim. The
best results were obtained by transferring the drops from
reservoirs containing 1.7 M ammonium sulfate (40 mg/ml
stock protein, 100 mM Tris, pH 8.4) to metastable conditions
ranging from 1.2 to 1.3 M ammonium sulfate. The largest
crystals (single crystals of sizes up to 0.6 3 0.3 3 0.2 mm
diffracting to 1.6 A˚—see Fig. 2 a) were obtained in drops
incubated for 6 or 7 h at the nucleation conditions and then
transferred over wells at 1.3 M ammonium sulfate (same
buffer). Transfers performed after shorter incubation times
resulted in clear drops. The high supersaturation controls
yielded mostly clusters (Fig. 2 b) or very small single crystals
(typically up to 20 mm in each dimension) which did not
diffract at all.
For C-phycocyanin, incubation times of 0, 30 min, 1 h, 2
h, 5 h, and 7 h were tried for the various conditions in the
nucleation zone shown in Fig. 1 b. Again, small crystals
grew overnight when left undisturbed at these chosen
conditions. By transferring the drops from reservoirs
containing concentrations of 1–1.4 M ammonium sulfate
(20 mg/ml stock protein, 40 mMMES, pH 6.1) to metastable
conditions ranging from 0.6 to 0.7 M ammonium sulfate
(final protein concentrations from 10 to 14 mg/ml) large
single crystals were obtained. Although equally good
crystals could eventually also be obtained in the low controls
after 6–8 weeks, the transfers resulted in the formation of
such crystals ([250 3 250 3 150 mm, diffracting to 1.9 A˚
on a table top x-ray generator; see Materials and Methods)
within one week (Fig. 3 a). This was achieved by incubating
the drops for 7 h at 1.1 M ammonium sulfate (20 mg/ml stock
protein, 40 mM MES, pH 6.1) and then transferring them
over wells at 0.6 M ammonium sulfate (same buffer). The
high supersaturation controls yielded clusters of very small
crystals, typically 40–50 mm in each dimension (Fig. 3 b).
This systematic approach has led to the crystallization
FIGURE 2 Trypsin crystals grown (a) after transfer of the drop to
metastable conditions (incubation time t ¼ 6 h), largest dimension of crystal
0.6 mm; and (b) at the nucleation conditions at which growth of the crystals
in Fig. 2 a was initiated, but not transferred to metastable conditions (same
magnification as Fig. 2 a).
FIGURE 1 Working phase diagram and supersolubility curve (a) for
trypsin and (b) for C-phycocyanin, established for the vapor diffusion
technique, around conditions described in the text. The arrows correspond to
dilution experiments yielding enhanced crystals in the metastable zone.
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conditions used for the determination of the x-ray structure
of C-phycocyanin to 1.4 A˚ at the Daresbury synchrotron
(manuscript in preparation). These are the highest resolution
crystals ever obtained for this protein (compared to the best
published diffraction limit of 2.0 A˚ of Toriumi et al., 2001).
Experiments were performed with C-phycocyanin and
another target protein (a-crustacyanin), to assess the effect of
the drop size and of the reservoir/drop volume ratio on the
time of appearance of the first visible crystals and on their
numbers and sizes. The drop volumes were typical of those
that are routinely used in crystallography laboratories,
mostly working with proteins which are limited in supply.
Thus, 2–6 ml drops were set up at three different ammonium
sulfate concentrations in the nucleation zone, at reservoir
volumes ranging from 150 ml to 1 ml (volume ratios in the
range 25–500). A difference in the size and number of
crystals obtained was observed only for the trials set at the
lowest ratio, 25 (6 ml drops over 150 ml reservoirs), leading
to a larger number of smaller crystals. (Note that 150 ml does
not fully cover the bottom of the Linbro plate). No
differences were observed from the next ratio, 67 (6 ml
drops over 400 ml reservoirs), upwards. At ratios $67, drop
size did not have an effect, except for increasing the overall
numbers (but not the sizes) of crystals in proportion to the
increase in drop volume. The number of crystals per unit
volume is thus kept roughly constant. No differences in the
time of appearance of the crystals were observed at any ratio
within the range studied. A wider range of drop volumes and
volume ratios was tested with lysozyme in sodium chloride
buffered solution, where 1, 2, 3, 4, 5, and 10 ml drops were
equilibrated against 300 ml and 1 ml reservoirs. The 1 and 10
ml drops displayed atypical behavior for both reservoir
volumes: the 1-ml drops yielded excessive nucleation and
small crystals, whereas in the 10-ml drops crystals appeared
more slowly, but were neither fewer nor larger. Intermediate
size drops showed no differences in sizes or time of
appearance of the crystals, as long as the reservoir/drop
volume ratio was above 60 (lower ratios slowed down the
appearance of crystals). The constant number per unit
volume rule was respected for all but the 1 ml drops. The
geometry of the vessels and the solution composition are
important parameters in the equilibration process (Luft et al.,
1994; Luft and DeTitta, 1995). We find that when using
Linbro plates and high ionic strength solutions, as was the
case here, only extreme volume ratios, or drop volumes that
lie outside the 2–6 ml range, may make a difference to the
final result and therefore to the timing and efficiency of the
dilution procedure. This is probably due to the fact that the
drops equilibrate quickly at the conditions used and therefore
the nucleation induction time, rather than the equilibration
time, becomes the limiting factor in the process.
Vapor diffusion systems involving solutions with high
concentrations of high molecular weight polyethylene
glycols (PEG) and low ionic strengths are very sensitive to
drop volume and take a longer time to equilibrate (Mikol
et al., 1990; Luft and DeTitta, 1995). The transfers therefore
need to be carried out after a longer incubation over initial
conditions reservoirs. Human serum albumin crystals,
obtained from 29–35% (w/v) PEG 3350 (Bhattacharya
et al., 2000), took 4 days to appear in 2 ml hanging drops.
Dilutions, by transfer to lower PEG concentrations, were
effective only 72 h after setup (Saridakis and Chayen, 2000).
Ignorance of the solubility curve may, of course, result in
some of the trials being transferred to undersaturated, rather
than metastable, conditions. This is more likely to occur if it
is attempted to transfer them to conditions at the lowest
possible supersaturation that is assumed to be metastable.
Such experiments, ending as ‘‘clear drops,’’ can possibly be
reset at nucleation conditions and transferred again to reach
true metastability, without loss of sample.
If needed, it is also possible to establish an approximate
solubility curve by transferring crystallization drops to
various conditions below the supersolubility curve. The
solubility curve is the boundary below which crystals will
FIGURE 3 C-phycocyanin crystals grown (a) after transfer of the drop to
metastable conditions (incubation time t ¼ 6 h), dimensions of largest
crystal 0.253 0.253 0.15 mm; and (b) at the nucleation conditions at which
growth of the crystals in Fig. 3 a was initiated, but not transferred to
metastable conditions (same magnification as Fig. 3 a).
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not appear after transfer, even after long initial incubations of
the transferred drops at nucleation conditions. In this case it
is desirable to leave the trials to incubate at nucleation
conditions for a longer time than would be most effective for
crystal optimization, in order not to overestimate the
solubility conditions. However, leaving them long enough
for large crystals to form risks leading to an underestimate of
the solubility conditions, because kinetic factors prevent
a crystal from dissolving easily even when surrounded by
unsaturated solution. The most reliable transfer time in this
case is just before the appearance of the first visible crystals,
that time being estimated from conventional trials set at the
nucleation conditions. A microbatch version of this method
has already been used to determine a phase diagram for the
crystallization of carboxypeptidase G2 (Saridakis et al.,
1994). The use of vapor diffusion is probably more reliable,
because ‘‘shock nucleation’’ is less likely.
However, and contrary to the common consensus that the
determination of the solubility curve is imperative for
successful rational nucleation-growth decoupling experi-
ments, we show here that, for practical purposes, it is
sufficient to obtain the supersolubility curve. The advantage
of this is that the experiments take a far shorter time
compared to solubility determinations which can take weeks
(or even months) and consume much larger quantities of
materials than those required for the working phase
diagrams.
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